(1)
Regeda-Furdychko, M. M. Pathogenetic Substantiation of Thiotriazoline Use on the Basis of Disorders of Proteolysis Processes and Protease Inhibitors under Conditions of Contact Dermatitis and Experimental Pneumonia. J Educ Health Sport 2019, 9, 584-589.